Previous Article | Next Article ![]()
Infect. Immun., May 1997, 1856-1862, Vol 65, No. 5
C Abou-Zeid, MP Gares, J Inwald, R Janssen, Y Zhang, DB Young, C Hetzel, JR Lamb, SL Baldwin, IM Orme, V Yeremeev, BV Nikonenko and AS Apt
A 19-kDa lipoprotein from Mycobacterium tuberculosis was expressed as a
recombinant antigen in the nonpathogenic mycobacterial host strain M.
vaccae. Immunization of mice with the recombinant M. vaccae resulted in
induction of a strong type 1 immune response to the 19-kDa antigen,
characterized by immunoglobulin G2a (IgG2a) antibodies and gamma interferon
(IFN-gamma) production by splenocytes. Immunization with the same antigen
in incomplete Freund's adjuvant induced a strong IgG1 response with only
low levels of IFN-gamma. Subsequent intravenous and aerosol challenges of
immunized mice with virulent M. tuberculosis demonstrated no evidence of
protection associated with the response to the 19-kDa antigen; in fact, the
presence of the recombinant 19-kDa antigen abrogated the limited protection
conferred by M. vaccae (vector control). The recombinant M. vaccae system
is a convenient approach to induction of type 1 responses to M.
tuberculosis antigens. However, the unexpected reduction in protective
efficacy of M. vaccae expressing the 19-kDa antigen highlights the
complexity of testing recombinant subunit vaccines and the need for a
better understanding of the immune mechanisms required for effective
vaccination against tuberculosis.
Copyright © 1997, American Society for Microbiology
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae
Department of Medical Microbiology, Imperial College School of Medicine at St. Mary's, London, United Kingdom. c.abouzeid@ic.ac.uk
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|